Form 4: USANA Health Sciences Director Xia Ding Reports Stock Transactions

Director Xia Ding of USANA Health Sciences Inc. reported the acquisition of 674 common stock units and the disposal of 169 common stock units on February 2, 2025.

Summary

• Xia Ding, a director at USANA Health Sciences Inc., filed a Form 4 indicating changes in beneficial ownership.
• On February 2, 2025, Ding acquired 674 shares of common stock through the vesting of restricted stock units.
• Also on February 2, 2025, Ding disposed of 169 shares of common stock at a price of $32.57 per share.
• Following these transactions, Ding directly owns 4,039 shares of USANA common stock.
• The restricted stock units vest in four tranches, with the final tranche vesting on May 2, 2025.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of stock transactions by a company director, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions reported are typical for directors receiving stock-based compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine insider activity.

Key Dates

Keywords

USANA Health Sciences, insider trading, Form 4, stock transaction, beneficial ownership, restricted stock units, Xia Ding, director